Peripheral Perfusion Index-guided Fluid Resuscitation for Preventing Acute Skin Failure in Elderly Critically Ill Patients
Key facts
- Who runs it
- Ying Wang
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 216 people, planned
- Started
- 1 Jan 2025
- Expected to end
- Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Peripheral Perfusion Index-guided Fluid Resuscitation Protocol
- Conventional Goal-Directed Fluid Resuscitation
- Record updated
- 9 April 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age ≥ 65 years
- Diagnosis of sepsis (according to Sepsis-3 criteria) or other types of shock requiring early and aggressive fluid resuscitation
- APACHE II score ≥ 15 at ICU admission
- Expected ICU length of stay ≥ 72 hours
- Written informed consent obtained from the patient or their legally authorized representative
Who cannot take part
- Expected survival < 24 hours due to terminal illness or irreversible condition. Concurrent participation in another interventional clinical trial
- Severe dermatological disease or peripheral vascular disease that could interfere with the assessment of skin or peripheral perfusion
- Contraindications to liberal fluid resuscitation (e.g., acute cardiogenic pulmonary edema, severe heart failure with fluid overload)
- Pre-existing stage III or higher pressure injury or skin necrosis at the time of enrollment
- Inability to perform continuous finger pulse oximetry monitoring (e.g., due to bilateral finger injury, amputation, or severe peripheral edema)
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, randomized, controlled trial aimed to evaluate whether fluid resuscitation guided by the Peripheral Perfusion Index (PPI) could reduce the incidence of Acute Skin Failure (ASF) in elderly critically ill patients. A total of 216 patients aged ≥65 years with sepsis or other types of shock requiring early aggressive fluid resuscitation were enrolled and randomly assigned in a 1:1 ratio to either the PPI-guided resuscitation group or the conventional resuscitation group. The intervention group targeted maintaining PPI ≥1.4 in addition to conventional hemodynamic goals, while the control group followed standard resuscitation protocols. The primary outcome was the incidence of ASF within 7 days of ICU admission, diagnosed according to NPUAP/EPUAP (2014) criteria. Secondary outcomes included time to ASF occurrence, lactate clearance, cumulative fluid balance, organ function, and long-term prognosis.
The 2 groups in the trial
- eripheral Perfusion Index-guided Fluid Resuscitation ProtocolTreatment being tested
Treatment: Peripheral Perfusion Index-guided Fluid Resuscitation Protocol
- Conventional Fluid Resuscitation GroupExisting treatment, for comparison
Treatment: Conventional Goal-Directed Fluid Resuscitation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Peripheral Perfusion Index-guided Fluid Resuscitation on the Prevention of Acute Skin Failure in Elderly Critically Ill Patients: A Prospective, Randomized, Controlled Trial
- Record updated
- 9 April 2026